Peter MacCallum - Concepedia

Author

Peter MacCallum

Also Known As

New Zealand, P MacCALLUM, P MacCallum, P. MacCallum, P. Maccallum, PETER MACCALLUM, PETER MacCALLUM, Pavel Lang, Peter MacCallum, Peter Maccallum

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

Queen Mary University of London Barts Health NHS Trust McMaster University Städtisches Klinikum Dresden Thrombosis Research Institute

About

Peter MacCallum is an author at Queen Mary University of London specializing in medicine, thrombosis, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	2.3K
2	Health Sciences	5	5	1.4K
3	Emergency Medicine	3	3	132
4	Public Health	2	2	64
5	Cell Biology	1	1	19

Peter MacCallum

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) Annie Young, Andrea Marshall, Jenny Thirlwall, Journal of Clinical Oncology Vte RecurrencePathologyPharmacotherapyThrombosisLow Vte Recurrence	2018	1.3K
Respiratory Viruses, Symptoms, and Inflammatory Markers in Acute Exacerbations and Stable Chronic Obstructive Pulmonary Disease Terence Seemungal, RHIAN HARPER-OWEN, Angshu Bhowmik, American Journal of Respiratory and Critical Care Medicine	2001	1K
Functional definition and characterization of acute traumatic coagulopathy Ross Davenport, Joanna Manson, Sean Platton, Critical Care Medicine	2011	513
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19 Louise Bowles, Sean Platton, Nada Yartey, New England Journal of Medicine	2020	498
A new mycobacterial infection in man Peter MacCallum, Jean C. Tolhurst, Glen Buckle, The Journal of Pathology and Bacteriology Pulmonary TuberculosisTuberculosisMicrobiologyInfection ControlMedicine	1948	469
Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels Terence Seemungal, Peter MacCallum, Elizabeth Paul, Thrombosis and Haemostasis	2000	447
Evaluation of laboratory assays for anti‐platelet factor 4 antibodies after ChAdOx1 nCOV‐19 vaccination Sean Platton, Andrew Bartlett, Peter MacCallum, Journal of Thrombosis and Haemostasis VaccinationVaccine DevelopmentBlood PlateletHematologyImmunology	2021	137
Cholecystitis glandularis proliferans (cystica) Emma King, Peter MacCallum British journal of surgery Melbourne SearchPathology UniversityBiliary TractSurgical PathologyPathogenesis	1931	63
Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma Mark J. Edwards, R. W. H. Walker, Sarah Vinnicombe, Annals of Oncology Hematological MalignancyLymphoid NeoplasiaMedicineSurgical PathologyHematology	2001	62
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial Frank Cools, Saverio Virdone, J.P.S. Sawhney, The Lancet Haematology ThrombosisPreventive MedicineAt-risk OutpatientsLong CovidThromboprophylactic Low-molecular-weight Heparin	2022	60

Page 1